MyFinsight
Home
Blog
About
Contact
Download
Download image
EXPAREL
$143,274K
ZILRETTA
$26,767K
Iovera
$6,176K
Bupivacaine Liposome
Injectable Suspension
$1,159K
Total revenues
$177,376K
(5.00%↑ Y/Y)
Income from operations
$6,902K
(246.83%↑ Y/Y)
Total operating
expenses
$170,474K
(2.12%↑ Y/Y)
Other operating
(gains) expenses, net
$2,277K
Income before income
taxes
$4,998K
(-42.59%↓ Y/Y)
Total other (expense)
income, net
-$1,904K
(-128.35%↓ Y/Y)
Interest income
$1,930K
(-72.01%↓ Y/Y)
Selling, general and
administrative
$93,944K
(8.26%↑ Y/Y)
Cost of goods sold
(exclusive of amortization...
$36,413K
(6.14%↑ Y/Y)
Research and development
$28,072K
(10.77%↑ Y/Y)
Amortization of acquired
intangible assets
$14,322K
(0.00%↑ Y/Y)
Net income
$2,916K
(-39.40%↓ Y/Y)
Income tax expense
$2,082K
(-46.53%↓ Y/Y)
Interest expense
$3,699K
(-19.24%↓ Y/Y)
Other, net
-$135K
(-103.07%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX)